FDA pulls the only approved drug for preventing premature birth off the market
The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.
by Sydney Lupkin
Apr 06, 2023
1 minute
The Food and Drug Administration is pulling its approval for a controversial drug that was intended to prevent premature births, but that studies showed wasn't effective.
Following years of back-and-forth between the agency and the drugmaker Covis Pharma, the FDA's
You’re reading a preview, subscribe to read more.
Start your free 30 days